Community pharmacy program to improve hypertension management in Bangladesh and Pakistan
Effectiveness of a Community Pharmacy-based Health Promotion Program on Hypertension in Bangladesh and Pakistan: Study Protocol for a Cluster Randomized Controlled Trial
This study is testing whether a community pharmacy program that offers training and support can help people with high blood pressure in Bangladesh and Pakistan manage their condition better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 3600 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Hitotsubashi University Academic / other |
| Locations | 1 site (Dhaka) |
| Trial ID | NCT06148142 on ClinicalTrials.gov |
What this trial studies
This project aims to reduce blood pressure among hypertensive individuals in Bangladesh and Pakistan over an 18-month period through a cluster randomized controlled trial. Approximately 3,600 hypertensive adults will participate, with community pharmacies randomly assigned to either an intervention or control group. The intervention includes educational training, counseling, and follow-up via phone calls and text messages to enhance medication adherence and health coordination. The study will assess the effectiveness and cost-effectiveness of this pharmacist-led approach in managing hypertension.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 to 90 with hypertension and suboptimal medication adherence who can communicate in the local language.
Not a fit: Patients who are pregnant, have advanced medical diseases, or cognitive and psychiatric issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve blood pressure control and overall health outcomes for hypertensive patients in South Asia.
How similar studies have performed: Other studies have shown success with pharmacist-led interventions in hypertension management, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 years to 90 years old * Hypertensive (SBP ≥140 mmHg and DBP ≥90 mmHg and/or taking antihypertensive medications) * Having suboptimal medication adherence to antihypertensive drugs * Capable of communicating verbally in local language * Permanent resident of the study area * Access to mobile phone * Consent to participate Pharmacists' inclusion criteria include: * Ensuring a sufficient amount of time to implement intervention on hypertensive participants * Consent to participate * Able to operate smartphone or tablet. Exclusion Criteria: * Pregnant and lactating women * Individuals with advanced medical disease * Those having cognitive and psychiatric problems, * Involvement in any other interventional study * Individuals who are unable to give informed consent.
Where this trial is running
Dhaka
- Global Public Health Research Foundation — Dhaka, Bangladesh (Recruiting)
Study contacts
- Study coordinator: Md. Mizanur Rahman, PhD
- Email: mizanurrub78@gmail.com
- Phone: +818035463610
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.